Health IT, Payers

Sachin Jain takes over leadership of CareMore

Dr. Jain said he’s keen to continue to expand CareMore to new populations as it has done in the Medicaid space in coordination with Amerigroup in Memphis, Tennessee and in Des Moines, Iowa, in an emailed statement.

A little more than one year after Dr. Sachin Jain moved from Merck to join Anthem subsidiary CareMore as Chief Medical Officer, he is moving again. This time, it’s up — to lead the company as its president, according to a company statement. The management shift comes as CareMore President Leeba Lessin retires this week.

CareMore’s main patient population has been high-cost, high-need seniors. In an emailed statement, Jain said he’s keen to continue to expand CareMore to new populations as it has done in the Medicaid space in coordination with Amerigroup in Memphis, Tennessee and in Des Moines, Iowa.

He added that CareMore would continue to champion provider collaboration such as with the Emory Health System in Atlanta. It would also add new technology to its care model, Jain said.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Lessin will stay on as a consultant for provider strategies and new business development initiatives. She will also work as an instructor and curriculum consultant for CareMore’s clinical training program for healthcare professionals.

Meanwhile, a search for a new chief medical officer at CareMore has begun.